CGTX
Price
$0.74
Change
+$0.06 (+8.82%)
Updated
Jan 21 closing price
Capitalization
30.75M
63 days until earnings call
DYAI
Price
$1.56
Change
+$0.06 (+4.00%)
Updated
Jan 21 closing price
Capitalization
46.16M
63 days until earnings call
Ad is loading...

CGTX vs DYAI

Header iconCGTX vs DYAI Comparison
Open Charts CGTX vs DYAIBanner chart's image
Cognition Therapeutics
Price$0.74
Change+$0.06 (+8.82%)
Volume$558.14K
Capitalization30.75M
Dyadic International
Price$1.56
Change+$0.06 (+4.00%)
Volume$70.72K
Capitalization46.16M
CGTX vs DYAI Comparison Chart
Loading...
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGTX vs. DYAI commentary
Jan 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGTX is a Hold and DYAI is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 22, 2025
Stock price -- (CGTX: $0.74 vs. DYAI: $1.56)
Brand notoriety: CGTX and DYAI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGTX: 5% vs. DYAI: 51%
Market capitalization -- CGTX: $30.75M vs. DYAI: $46.16M
CGTX [@Biotechnology] is valued at $30.75M. DYAI’s [@Biotechnology] market capitalization is $46.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $341.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGTX’s FA Score shows that 1 FA rating(s) are green whileDYAI’s FA Score has 0 green FA rating(s).

  • CGTX’s FA Score: 1 green, 4 red.
  • DYAI’s FA Score: 0 green, 5 red.
According to our system of comparison, CGTX is a better buy in the long-term than DYAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGTX’s TA Score shows that 2 TA indicator(s) are bullish while DYAI’s TA Score has 4 bullish TA indicator(s).

  • CGTX’s TA Score: 2 bullish, 6 bearish.
  • DYAI’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, DYAI is a better buy in the short-term than CGTX.

Price Growth

CGTX (@Biotechnology) experienced а +3.64% price change this week, while DYAI (@Biotechnology) price change was -0.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.46%. For the same industry, the average monthly price growth was +2.44%, and the average quarterly price growth was -0.25%.

Reported Earning Dates

CGTX is expected to report earnings on May 07, 2025.

DYAI is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (+2.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYAI($46.2M) has a higher market cap than CGTX($30.7M). CGTX YTD gains are higher at: 5.518 vs. DYAI (-10.857). DYAI has higher annual earnings (EBITDA): -7.42M vs. CGTX (-33.98M). CGTX has more cash in the bank: 22M vs. DYAI (9.92M). CGTX has less debt than DYAI: CGTX (580K) vs DYAI (5.37M). DYAI has higher revenues than CGTX: DYAI (3.37M) vs CGTX (0).
CGTXDYAICGTX / DYAI
Capitalization30.7M46.2M66%
EBITDA-33.98M-7.42M458%
Gain YTD5.518-10.857-51%
P/E RatioN/AN/A-
Revenue03.37M-
Total Cash22M9.92M222%
Total Debt580K5.37M11%
FUNDAMENTALS RATINGS
DYAI: Fundamental Ratings
DYAI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGTXDYAI
RSI
ODDS (%)
Bearish Trend 9 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 9 days ago
90%
Bullish Trend 9 days ago
88%
Momentum
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 9 days ago
90%
MACD
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 9 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 9 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 9 days ago
81%
Bearish Trend 9 days ago
87%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 17 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 9 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 9 days ago
79%
View a ticker or compare two or three
Ad is loading...
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X106146.2660004129.601600
+4.05%
Bitcoin cryptocurrency
SPY603.055.47
+0.92%
SPDR® S&P 500® ETF Trust
GME27.47-0.04
-0.15%
GameStop Corp
TSLA424.07-2.43
-0.57%
Tesla
AAPL222.64-7.34
-3.19%
Apple

CGTX and

Correlation & Price change

A.I.dvisor tells us that CGTX and SNDX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGTX and SNDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGTX
1D Price
Change %
CGTX100%
+8.54%
SNDX - CGTX
32%
Poorly correlated
+4.51%
BRCTF - CGTX
30%
Poorly correlated
-0.64%
RNTX - CGTX
29%
Poorly correlated
-3.00%
VTVT - CGTX
28%
Poorly correlated
-0.60%
JSPR - CGTX
26%
Poorly correlated
+3.45%
More

DYAI and

Correlation & Price change

A.I.dvisor tells us that DYAI and CGTX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DYAI and CGTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYAI
1D Price
Change %
DYAI100%
+4.00%
CGTX - DYAI
26%
Poorly correlated
+8.54%
VYNE - DYAI
24%
Poorly correlated
+2.59%
NAUT - DYAI
23%
Poorly correlated
+5.70%
LEGN - DYAI
23%
Poorly correlated
+6.15%
FBRX - DYAI
23%
Poorly correlated
-5.77%
More